Literature DB >> 21596085

HIV-Gag VLPs presenting trimeric HIV-1 gp140 spikes constitutively expressed in stable double transfected insect cell line.

M Tagliamonte1, M L Visciano, M L Tornesello, A De Stradis, F M Buonaguro, L Buonaguro.   

Abstract

We have previously described the establishment and characterization of a stably transfected insect cell line for the constitutive and efficient expression of Pr55 HIV Gag proteins, which auto-assemble into enveloped Virus-Like Particles (VLPs) released into the cell culture supernatant. Such HIV-Gag VLPs have been shown to elicit a specific systemic humoral response in vivo, proving the appropriate antigenic presentation of the HIV Gag protein to the immune system. Here we describe the establishment of a stable double transfected insect cell line for the constitutive and reproducible production of Pr55Gag-VLPs expressing on their surface trimeric forms of HIV-1 envelope glycoproteins. The persistence of HIV coding genes has been verified in clonal resistant insect cells, the protein expression and conformation has been verified by Western blot analysis. The resulting HIV-VLPs have been visualized by standard transmission electron microscopy and their immunogenicity has been evaluated in vivo. This represents, to our knowledge, the first example of stable double transfected insect cell line for the constitutive production of enveloped HIV-Gag VLPs presenting trimeric HIV-gp140 on their surface.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21596085     DOI: 10.1016/j.vaccine.2011.05.004

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Immunogenicity of HIV virus-like particles in rhesus macaques by intranasal administration.

Authors:  Luigi Buonaguro; Maria Tagliamonte; Maria Luisa Visciano; Hanne Andersen; Mark Lewis; Ranajit Pal; Maria Lina Tornesello; Ulf Schroeder; Jorma Hinkula; Britta Wahren; Franco M Buonaguro
Journal:  Clin Vaccine Immunol       Date:  2012-03-29

2.  Can Virus-like Particles Be Used as Synergistic Agent in Pest Management?

Authors:  Caroline Deshayes; Anne-Sophie Gosselin-Grenet; Mylène Ogliastro; Bruno Lapied; Véronique Apaire-Marchais
Journal:  Viruses       Date:  2022-04-30       Impact factor: 5.818

3.  Effects of adjuvants on IgG subclasses elicited by virus-like particles.

Authors:  Maria Luisa Visciano; Maria Tagliamonte; Maria Lina Tornesello; Franco M Buonaguro; Luigi Buonaguro
Journal:  J Transl Med       Date:  2012-01-05       Impact factor: 5.531

4.  Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate.

Authors:  Maria Luisa Visciano; Maria Tagliamonte; Guillaume Stewart-Jones; Leo Heyndrickx; Guido Vanham; Marianne Jansson; Anders Fomsgaard; Berit Grevstad; Meghna Ramaswamy; Franco M Buonaguro; Maria Lina Tornesello; Priscilla Biswas; Gabriella Scarlatti; Luigi Buonaguro
Journal:  J Transl Med       Date:  2013-07-08       Impact factor: 5.531

Review 5.  Production of virus-like particles for vaccines.

Authors:  J Fuenmayor; F Gòdia; L Cervera
Journal:  N Biotechnol       Date:  2017-08-01       Impact factor: 5.079

Review 6.  Viral vaccines and their manufacturing cell substrates: New trends and designs in modern vaccinology.

Authors:  Ana F Rodrigues; Hugo R Soares; Miguel R Guerreiro; Paula M Alves; Ana S Coroadinha
Journal:  Biotechnol J       Date:  2015-07-24       Impact factor: 4.677

Review 7.  Design Concepts of Virus-Like Particle-Based HIV-1 Vaccines.

Authors:  Chun-Wei Chen; Narcís Saubi; Joan Joseph-Munné
Journal:  Front Immunol       Date:  2020-09-30       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.